Molecular Classification of Oral Squamous Cell Carcinoma
- PMID: 27790599
- PMCID: PMC5072099
- DOI: 10.7860/JCDR/2016/19967.8565
Molecular Classification of Oral Squamous Cell Carcinoma
Abstract
Oral Squamous Cell Carcinoma (OSCC) is the commonest tumour in the oro-facial region with increasing incidence in the recent years. The disease is challenging as it still depicts a high morbidity and mortality rate. Clinico-pathological data, tumour site, pathologic site tumor, lymphnode, metastasis (TNM) staging, histological grade, invasion, perineural invasion and metastasis have been evaluated to a great depth in relation to OSCC. Co-morbidity factors like use of tobacco, alcohol consumption and various other factors including genetic predisposition have been looked at for finding a suitable treatment protocol. The crux of the matter in understanding the complexity of oral cancer lies in the biological heterogeneity of the tumour. Similar heterogeneity is seen in clinical presentation, histopathology and molecular changes at the cellular level. In spite of the disease being diagnosed, a prediction of the same related to behaviour has remained elusive. Hence, it is time to look beyond at the genetic and epigenetic events leading to molecular and cytogenetic changes that elucidate the pathogenesis and help in design and implementation of targeted drug therapy. A molecular classification of OSCC needs to be put in place much before a clinician can design the treatment protocol of the same and predict the prognosis.
Keywords: Cancer biology; Epigenetics; Gene expression; Gene therapy/therapeutics.
Similar articles
-
Development of a New Outcome Prediction Model in Early-stage Squamous Cell Carcinoma of the Oral Cavity Based on Histopathologic Parameters With Multivariate Analysis: The Aditi-Nuzhat Lymph-node Prediction Score (ANLPS) System.Am J Surg Pathol. 2017 Jul;41(7):950-960. doi: 10.1097/PAS.0000000000000843. Am J Surg Pathol. 2017. PMID: 28346327
-
Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.J Pathol. 2015 Aug;236(4):505-16. doi: 10.1002/path.4550. Epub 2015 Jun 1. J Pathol. 2015. PMID: 25925492
-
Oral squamous cell carcinoma in the background of oral submucous fibrosis is a distinct clinicopathological entity with better prognosis.J Oral Pathol Med. 2017 Jul;46(6):448-453. doi: 10.1111/jop.12553. Epub 2017 Feb 28. J Oral Pathol Med. 2017. PMID: 28129456
-
Molecular changes in invasive front of oral cancer.J Oral Maxillofac Pathol. 2013 May;17(2):240-7. doi: 10.4103/0973-029X.119740. J Oral Maxillofac Pathol. 2013. PMID: 24250086 Free PMC article. Review.
-
Recent Advances in Understanding Carcinogenicity of Oral Squamous Cell Carcinoma: From Basic Molecular Biology to Latest Genomic and Proteomic Findings.Cancer Genomics Proteomics. 2004 Jul-Aug;1(4):283-294. Epub 2004 Jul 1. Cancer Genomics Proteomics. 2004. PMID: 31394607 Review.
Cited by
-
Current Status, Opportunities, and Challenges of Exosomes in Oral Cancer Diagnosis and Treatment.Int J Nanomedicine. 2022 Jun 16;17:2679-2705. doi: 10.2147/IJN.S365594. eCollection 2022. Int J Nanomedicine. 2022. PMID: 35733418 Free PMC article. Review.
-
METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m6A Methylation in Oral Squamous Cell Carcinoma.Mol Ther. 2020 Oct 7;28(10):2177-2190. doi: 10.1016/j.ymthe.2020.06.024. Epub 2020 Jun 24. Mol Ther. 2020. PMID: 32621798 Free PMC article.
-
The Expression Patterns and Associated Clinical Parameters of Human Endogenous Retrovirus-H Long Terminal Repeat-Associating Protein 2 and Transmembrane and Immunoglobulin Domain Containing 2 in Oral Squamous Cell Carcinoma.Dis Markers. 2019 Apr 7;2019:5421985. doi: 10.1155/2019/5421985. eCollection 2019. Dis Markers. 2019. PMID: 31089395 Free PMC article.
-
Mapping Cell-in-Cell Structures in Oral Squamous Cell Carcinoma.Cells. 2023 Oct 8;12(19):2418. doi: 10.3390/cells12192418. Cells. 2023. PMID: 37830632 Free PMC article.
-
Combination RSL3 Treatment Sensitizes Ferroptosis- and EGFR-Inhibition-Resistant HNSCCs to Cetuximab.Int J Mol Sci. 2022 Aug 12;23(16):9014. doi: 10.3390/ijms23169014. Int J Mol Sci. 2022. PMID: 36012290 Free PMC article.
References
-
- Chung HC, Parker JS, Karaca G, Wu J, Funkhouser W K, Moore D, et al. Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell. 2004;(5):489–500. - PubMed
-
- Doshi NP, Shah SA, Patel KB, Jhabuawala MF. Histological grading of oral cancer: A comparison of different systems and their relation to lymph node metastasis. Ntl J of Community Med. 2011;2(1):136–42.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources